Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
METIS Innovative is a venture capital firm founded in 2017 by two neurosurgeons and a capital accrual expert. Based in the United States, the firm focuses on early-stage investments in the neurotechnology sector, specifically targeting medical devices and technologies for neurologic conditions. They manage a portfolio of eight companies.
METIS Innovative invests in pre-seed to Series A companies developing medical devices and technologies aimed at treating neurologic conditions. Their investment strategy integrates clinical insights from practicing neurosurgeons with rigorous financial analysis to pinpoint high-potential opportunities in the neurotechnology field.
Notable portfolio companies include Synchron, a leader in brain-computer interfaces; Fluid Biomed, developing a polymer-based brain stent; Proprio, modernizing surgical practices; Precision Recovery, providing virtual care for stroke recovery; Aurenar, creating a wearable neuromodulation device; Phantom Neuro, enhancing human-machine interaction; Reach Neuro, restoring movement for stroke survivors; and Von Vascular, innovating in thrombectomy technologies.
Submit your pitch through their website contact form for consideration.
Yes, METIS Innovative often leads investment rounds, particularly in early-stage companies where they can provide significant clinical insights.
The firm is open to follow-on investments in portfolio companies that demonstrate strong growth and potential for further development in the neurotechnology space.
Specific details about the fund size are not publicly available, but the firm focuses on early-stage investments in the biotech and healthcare sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.